MPU vs CURI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 11, 2026

MPU

37.2
AI Score
VS
MPU Wins

CURI

35.0
AI Score

Investment Advisor Scores

MPU

37score
Recommendation
AVOID NEW MONEY

CURI

35score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric MPU CURI Winner
Forward P/E 3.9463 9.2937 MPU
PEG Ratio 0 0 Tie
Revenue Growth -25.8% 22.3% CURI
Earnings Growth 0.0% 1400.0% CURI
Tradestie Score 37.2/100 35.0/100 MPU
Profit Margin -168.3% 0.0% CURI
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

MPU 1M: +1341.3% · 3M: +1006.9% CURI 1M: +3.3% · 3M: +8.9%

Current Technical Phase

MPU

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (416.2% over 20 days), RSI 66

RSI (14): 66.5 · Price: $2.75

CURI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.6 · Price: $2.80

Fundamentals Snapshot

Metric MPU CURI
Market Cap — —
Forward P/E 3.9 9.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.3% 0.2%
Gross Margin 0.6% 0.6%
Operating Margin -0.6% 0.4%
EPS -13.65 0.00
Dividend Yield — 0.11%

Frequently Asked Questions

Based on our detailed analysis, MPU is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.